Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026)

Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Ovid Therapeutics 385.37 Mn 229.84 Mn - 136.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 136.17 Mn
Dec 31, 2025 73.74 Mn
Sep 30, 2025 71.11 Mn
Jun 30, 2025 71.11 Mn
Mar 31, 2025 71.05 Mn
Dec 31, 2024 70.91 Mn
Sep 30, 2024 70.98 Mn
Jun 30, 2024 71.20 Mn
Mar 31, 2024 70.72 Mn
Dec 31, 2023 70.58 Mn
Sep 30, 2023 70.62 Mn
Jun 30, 2023 70.53 Mn
Mar 31, 2023 70.49 Mn
Dec 31, 2022 70.42 Mn
Sep 30, 2022 70.43 Mn
Jun 30, 2022 70.39 Mn
Mar 31, 2022 70.35 Mn
Dec 31, 2021 68.07 Mn
Sep 30, 2021 67.93 Mn
Jun 30, 2021 67.82 Mn